Keywords: Dr Reddy's Laboratories, Second-quarter fiscal 2011/12

Dr Reddy’s 2nd-qtr net profit and sales rises beats forecasts

Article | 26 October 2011

Print This

India’s second-largest drugmaker Dr Reddy’s Laboratories (NYSE: RDY) posted a strong set of financial results for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in